NYSE - Delayed Quote • USD
Teladoc Health, Inc. (TDOC)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 22 | 19 |
| Avg. Estimate | -0.3 | -0.23 | -1.04 | -0.69 |
| Low Estimate | -0.41 | -0.31 | -1.38 | -1.17 |
| High Estimate | -0.17 | -0.18 | -0.73 | -0.16 |
| Year Ago EPS | -0.4 | -0.35 | -1.34 | -1.04 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 25 | 25 | 26 | 25 |
| Avg. Estimate | 661.4M | 676.64M | 2.66B | 2.76B |
| Low Estimate | 642.6M | 670M | 2.64B | 2.72B |
| High Estimate | 678.31M | 687.76M | 2.69B | 2.79B |
| Year Ago Sales | 649.19M | 664.11M | 2.6B | 2.66B |
| Sales Growth (year/est) | 1.90% | 1.90% | 2.40% | 3.50% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.37 | -0.21 | -0.46 |
| EPS Actual | -0.4 | -0.35 | -0.17 | -0.49 |
| Difference | 0.01 | 0.02 | 0.04 | -0.03 |
| Surprise % | 2.40% | 5.40% | 19.00% | -6.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.3 | -0.23 | -1.04 | -0.69 |
| 7 Days Ago | -0.3 | -0.23 | -1.04 | -0.69 |
| 30 Days Ago | -0.3 | -0.23 | -1.03 | -0.7 |
| 60 Days Ago | -0.29 | -0.22 | -1.02 | -0.69 |
| 90 Days Ago | -0.35 | -0.3 | -1.23 | -0.94 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | 1 | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TDOC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 5.40% |
| Next Qtr. | 34.30% | -- | -- | 10.90% |
| Current Year | 22.40% | -- | -- | 4.50% |
| Next Year | 33.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -29.03% | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Oppenheimer: Outperform to Outperform | 4/26/2024 |
| Maintains | TD Cowen: Hold to Hold | 4/26/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/26/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 4/26/2024 |
| Maintains | Stifel: Hold to Hold | 4/26/2024 |
| Maintains | Barclays: Overweight to Overweight | 4/26/2024 |
Related Tickers
DOCS Doximity, Inc.
23.82
+0.97%
SDGR Schrödinger, Inc.
23.97
+2.70%
TXG 10x Genomics, Inc.
27.59
+2.57%
AMWL American Well Corporation
0.5280
-2.13%
VEEV Veeva Systems Inc.
200.91
+0.91%
GEHC GE HealthCare Technologies Inc.
86.24
+0.34%
GDRX GoodRx Holdings, Inc.
7.19
+1.55%
MNDR Mobile-health Network Solutions
23.99
+0.88%
SOLV Solventum Corporation
64.43
+4.21%
ACCD Accolade, Inc.
7.89
-14.15%